Andersen E S, Nielsen K, Pedersen B
Department of Obstetrics and Gynecology, Aalborg Hospital, Denmark.
Gynecol Oncol. 1995 Oct;59(1):143-7. doi: 10.1006/gyno.1995.1281.
The accuracy of preconization cytology and histology was evaluated in 536 patients undergoing combination laser conization. Exact agreement between cytology and cone diagnosis was observed in 41.8% of the patients. The lowest agreement, 13.6% was demonstrated in cytologic cervical intraepithelial neoplasia (CIN) I, the highest in cytologic CIN III, 64.3%. Concerning microinvasive disease, the positive predictive value of cytology was only 27.3%; the negative predictive value 94.6%. When cytology showed CIN II or worse, the cone biopsy showed CIN or invasive disease in 92.8%. Exact agreement between preconization histology and the cone biopsy was found in 59.5%. Highest agreement was observed in CIN III lesions, 67.1%, and the lowest agreement in CIN II lesions, 42.7%. When preconization showed CIN II, a higher grade of lesion was found in the cone biopsy in 29.1%. Cone biopsy revealed invasive disease in 38 cases. In 24 cases, invasive disease was not demonstrated prior to conization, corresponding totally to 4.7% of patients not suspected to have invasive disease prior to conization. Regarding invasive disease, the sensitivity of preconization histology was 36.8%, the positive predictive value 58.3%, and the negative predictive value 95.3%. Kappa statistics demonstrated rather low agreement between cone diagnoses and preconization diagnoses. These results confirm the potential risk of overlooking invasive disease by conventional preconization evaluation and demonstrate the need for excisional methods in the management of cervical intraepithelial neoplasia to provide a sufficient specimen for diagnostic purposes. Combined with the therapeutic results, combination laser conization was a reliable diagnostic and therapeutic method in the management of patients with CIN and microinvasive cancer of the cervix.
对536例接受联合激光锥切术的患者进行了术前细胞学和组织学检查准确性的评估。41.8%的患者细胞学检查与锥切诊断完全一致。细胞学检查显示宫颈上皮内瘤变(CIN)I时一致性最低,为13.6%;细胞学检查显示CIN III时一致性最高,为64.3%。对于微浸润性疾病,细胞学检查的阳性预测值仅为27.3%;阴性预测值为94.6%。当细胞学检查显示为CIN II或更严重病变时,锥切活检显示为CIN或浸润性疾病的比例为92.8%。术前组织学检查与锥切活检完全一致的比例为59.5%。CIN III病变的一致性最高,为67.1%;CIN II病变的一致性最低,为42.7%。当术前显示为CIN II时,锥切活检中发现更高等级病变的比例为29.1%。锥切活检发现38例浸润性疾病。在24例中,锥切术前未显示浸润性疾病,这完全对应于锥切术前未怀疑有浸润性疾病患者的4.7%。对于浸润性疾病,术前组织学检查的敏感性为36.8%,阳性预测值为58.3%,阴性预测值为95.3%。kappa统计显示锥切诊断与术前诊断之间的一致性相当低。这些结果证实了传统术前评估可能遗漏浸润性疾病的潜在风险,并表明在宫颈上皮内瘤变的管理中需要采用切除方法以提供足够的标本用于诊断目的。结合治疗结果,联合激光锥切术是治疗CIN和宫颈微浸润癌患者的一种可靠的诊断和治疗方法。